Cargando…
Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities
BACKGROUND: Giant cell tumor (GCT) is a nonmalignant neoplasm composed of multinucleated giant and mononuclear stromal cells. This study aimed to compare imaging findings of GCT pre- and post-denosumab treatment, including lesion size, percentage of signal intensity/density change, and time of initi...
Autores principales: | Alothman, Maram, Althobaity, Waleed, Asiri, Yasser, Alreshoodi, Saleh, Alismail, Khalid, Alshaalan, Meshal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046877/ https://www.ncbi.nlm.nih.gov/pubmed/32108273 http://dx.doi.org/10.1186/s13244-020-00845-y |
Ejemplares similares
-
Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone
por: Lipplaa, Astrid, et al.
Publicado: (2019) -
Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh, Arun S, et al.
Publicado: (2015) -
'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015) -
A Recurrent Giant Cell Tumor of Bone Treated with Denosumab
por: Stadler, Nicola, et al.
Publicado: (2015) -
Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
por: Egbert, Ryan Carlisle, et al.
Publicado: (2017)